ACON Injectable Investors I
Washington, US · Founded 2021
Biotech
Founders & leadership
MY
Masumi Y. WaidaExecutive Officer
TY
Teresa Y. BernsteinExecutive Officer
JK
Jose KnoellManaging Director of the General Partner of the Issuer.
Reported raises · per SEC filings
Form D private placements$59MraisedJun 2021 · 3 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.